Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,867 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03407716 | Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors | completed | Early Phase 1 | 2 | Mayo ClinicOTHER | 1 | Jan 5, 2023 | clinicaltrials |
| NCT02013492 | Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery | completed | Early Phase 1 | 1 | William CarsonOTHER | 1 | Dec 6, 2022 | clinicaltrials |
| NCT05622240 |
| 99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer |
| unknown |
| Early Phase 1 |
| 30 |
| Peking Union Medical College HospitalOTHER |
| 1 |
| Nov 21, 2022 |
| clinicaltrials |
| NCT04797728 | Elacestrant in Preoperative Setting, a Window of Opportunity Study(ELIPSE) | completed | Early Phase 1 | 23 | SOLTI Breast Cancer Research GroupOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT04130152 | Palbociclib Plus Letrozole in Hormone Receptor Positive Residual Disease After Neoadjuvant Chemotherapy(PROMETEO II) | completed | Early Phase 1 | 22 | SOLTI Breast Cancer Research GroupOTHER | 1 | Oct 25, 2022 | clinicaltrials |
| NCT02065609 | 89ZrTrastuzumab Breast Imaging With Positron Emission Tomography | completed | Early Phase 1 | 52 | Washington University School of MedicineOTHER | 1 | Oct 13, 2022 | clinicaltrials |
| NCT04267900 | 99mTc-HPArk2 SPECT/CT for the Detection of HER2-positive Breast Cancer | completed | Early Phase 1 | 34 | Peking Union Medical College HospitalOTHER | 1 | Sep 14, 2022 | clinicaltrials |
| NCT05505812 | Study on the Safety and Efficacy of Autogenous Tumor Infiltrates Lymphocytes for the Treatment of Advanced Breast Cancer | not yet recruiting | Early Phase 1 | 10 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Aug 18, 2022 | clinicaltrials |
| NCT04102618 | A Window-of-opportunity Study of Pelareorep in Early Breast Cancer(AWARE-1) | terminated | Early Phase 1 | 26 | Oncolytics BiotechINDUSTRY | 1 | Aug 15, 2022 | clinicaltrials |
| NCT04019834 | Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy(RELIEF) | completed | Early Phase 1 | 21 | University of Alabama at BirminghamOTHER | 1 | Aug 3, 2022 | clinicaltrials |
| NCT04630210 | Investigating Atezolizumab in Newly Diagnosed ER Positive Breast Cancer Patients According to Their AdipOsity(AteBrO) | withdrawn | Early Phase 1 | 0 | Universitaire Ziekenhuizen KU LeuvenOTHER | 0 | Jun 15, 2022 | clinicaltrials |
| NCT04142892 | Onapristone as Preoperative Treatment for Postmenopausal Women With Hormone Receptor + and HER2- Breast Cancer(ONAWA) | completed | Early Phase 1 | 10 | SOLTI Breast Cancer Research GroupOTHER | 1 | Apr 1, 2022 | clinicaltrials |
| NCT05180851 | Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study(YSCH-01) | unknown | Early Phase 1 | 28 | Shanghai Fengxian District Central HospitalOTHER | 1 | Feb 1, 2022 | clinicaltrials |
| NCT03691311 | Biomarker Study of the Antitumoral Activity of Denosumab in the Pre- Operative Setting of Early Breast Cancer(D-BIOMARK) | unknown | Early Phase 1 | 60 | Institut Català d'OncologiaOTHER | 1 | Nov 3, 2021 | clinicaltrials |
| NCT01434342 | Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients | completed | Early Phase 1 | 146 | Wake Forest University Health SciencesOTHER | 1 | Sep 28, 2021 | clinicaltrials |
| NCT03197389 | Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer. | completed | Early Phase 1 | 54 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | May 19, 2021 | clinicaltrials |
| NCT03661892 | Pilot, Syndros, Decreasing Use of Opioids in Breast Cancer Subjects With Bone Mets | completed | Early Phase 1 | 14 | University of ArizonaOTHER | 1 | Apr 29, 2021 | clinicaltrials |
| NCT01796041 | Intraoperative Imaging of Breast Cancer With Indocyanine Green(ICG) | completed | Early Phase 1 | 10 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jan 28, 2021 | clinicaltrials |
| NCT02936999 | Vitamin D Supplementation in Women With DCIS and/or LCIS | terminated | Early Phase 1 | 8 | Inova Health Care ServicesOTHER | 1 | Dec 16, 2020 | clinicaltrials |
| NCT03295695 | PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient | withdrawn | Early Phase 1 | 0 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2020 | clinicaltrials |
| NCT02590458 | Feasibility of Short Breast MRI (SBMRI) for Screening Patients at High Risk for Breast Cancer | completed | Early Phase 1 | 131 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 1, 2020 | clinicaltrials |
| NCT00727948 | The Effect of Aspirin on Angiogenesis Proteins in Women on Tamoxifen Therapy | completed | Early Phase 1 | 11 | University of VermontOTHER | 1 | Sep 17, 2020 | clinicaltrials |
| NCT01875666 | Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib | completed | Early Phase 1 | 26 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Sep 4, 2020 | clinicaltrials |
| NCT01467310 | Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212 | completed | Early Phase 1 | 15 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Sep 2, 2020 | clinicaltrials |
| NCT02900469 | Presurgical Trial of Denosumab in Breast Cancer | completed | Early Phase 1 | 44 | NYU Langone HealthOTHER | 1 | Aug 21, 2020 | clinicaltrials |
| NCT00949247 | Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases | completed | Early Phase 1 | 20 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 27, 2020 | clinicaltrials |
| NCT02352025 | S-equol in Women With Triple Negative Breast Cancer | completed | Early Phase 1 | 39 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04088032 | Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer | withdrawn | Early Phase 1 | 0 | Alison StopeckOTHER | 1 | Jul 16, 2020 | clinicaltrials |
| NCT01823991 | COGNUTRIN in Breast Cancer Survivors | completed | Early Phase 1 | 36 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT00510367 | Primary Breast Cancer Occurring Concomitant With Pregnancy | completed | Early Phase 1 | 61 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 10, 2020 | clinicaltrials |
| NCT02802098 | Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer | completed | Early Phase 1 | 25 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Jun 19, 2020 | clinicaltrials |
| NCT01479348 | Imaging Study for FdCyd and THU Cancer Treatment | terminated | Early Phase 1 | 5 | National Cancer Institute (NCI)NIH | 1 | Jun 2, 2020 | clinicaltrials |
| NCT03004534 | A Study to Evaluate Changes in Human Breast Cancer Tissue Following Short-Term Use of Darolutamide | completed | Early Phase 1 | 36 | Translational Research in OncologyOTHER | 3 | Apr 3, 2020 | clinicaltrials |
| NCT03592121 | Study to Investigate the Effect of AB-101 in Breast Cancer Survivors | completed | Early Phase 1 | 3 | Applied Biology, Inc.INDUSTRY | 1 | Mar 12, 2020 | clinicaltrials |
| NCT00331630 | Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer | completed | Early Phase 1 | 30 | Northwestern UniversityOTHER | 1 | Mar 6, 2020 | clinicaltrials |
| NCT04289532 | Integrin α6-targeted SPECT Imaging of Breast Cancer | completed | Early Phase 1 | 9 | Peking UniversityOTHER | 1 | Mar 6, 2020 | clinicaltrials |
| NCT01380353 | Test Uniformity of Transdermal Drug Delivery to Breast Using Diclofenac Epolamine | completed | Early Phase 1 | 30 | Northwestern UniversityOTHER | 1 | Feb 19, 2020 | clinicaltrials |
| NCT03295916 | Stereotactic Body Radiotherapy for Patients With Breast Cancer Oligometastasis(STOMP) | unknown | Early Phase 1 | 30 | Juravinski Cancer CenterOTHER | 1 | Jan 29, 2020 | clinicaltrials |
| NCT04145323 | Novel Application of Indocyanine Green as a Biomarker to Identify Tissue Necrosis in Mastectomy Patients | completed | Early Phase 1 | 10 | University of Wisconsin, MadisonOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT01086696 | A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers | terminated | Early Phase 1 | 6 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT01894451 | Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy | completed | Early Phase 1 | 2 | Dana-Farber Cancer InstituteOTHER | 1 | Dec 12, 2019 | clinicaltrials |
| NCT01263613 | Feasibility Study of Biomarkers of Response to Neoadjuvant Paclitaxel in Locally Advanced Breast Cancer | completed | Early Phase 1 | 6 | University of Wisconsin, MadisonOTHER | 1 | Nov 19, 2019 | clinicaltrials |
| NCT01753908 | Broccoli Sprout Extract in Treating Patients With Breast Cancer | completed | Early Phase 1 | 30 | Roswell Park Cancer InstituteOTHER | 1 | Oct 31, 2019 | clinicaltrials |
| NCT04130750 | Comparison of pCR Rate After Neadjuvant Chemotherapy Guided by Result of in Vitro Cell Culture Drug Sensitivity or Physician's Choice | unknown | Early Phase 1 | 200 | Peking University People's HospitalOTHER | 1 | Oct 17, 2019 | clinicaltrials |
| NCT04113096 | Dibenzyl Trisulphide (GUINEAHEN WEED) for Stage IV Cancer | unknown | Early Phase 1 | 104 | The University of The West IndiesOTHER | 1 | Oct 8, 2019 | clinicaltrials |
| NCT02316795 | Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma | completed | Early Phase 1 | 20 | Washington University School of MedicineOTHER | 1 | Sep 24, 2019 | clinicaltrials |
| NCT01730729 | Cabergoline in Metastatic Breast Cancer | completed | Early Phase 1 | 20 | Northwestern UniversityOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT02806817 | ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism | completed | Early Phase 1 | 40 | Centro Nacional de Investigaciones Oncologicas CARLOS IIIOTHER | 1 | Jul 23, 2019 | clinicaltrials |
| NCT01138553 | Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast Cancer | terminated | Early Phase 1 | 4 | University of California, San DiegoOTHER | 1 | Jul 8, 2019 | clinicaltrials |
| NCT01660529 | Multi-peptide Vaccine With Basilixumab for Breast Cancer | completed | Early Phase 1 | 10 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jun 25, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Jan 5, 2023source: clinicaltrials